Distinct genetic pathways define pre-malignant versus compensatory clonal hematopoiesis in Shwachman-Diamond syndrome
Alyssa L. Kennedy(Boston Children's Hospital), R. Coleman Lindsley(Dana-Farber Cancer Institute)
Cited by 172
Related Papers
Functional, chemical genomic, and super-enhancer screening identify sensitivity to cyclin D1/CDK4 pathway inhibition in Ewing sarcoma
|Oncotarget|2015|98
Distinct genetic pathways define pre-leukemic and compensatory clonal hematopoiesis in Shwachman-Diamond syndrome
|bioRxiv (Cold Spring Harbor Laboratory)|2020|6
<i>BCOR</i> and <i>BCORL1</i> mutations disrupt PRC1.1 repressive function in leukemia by unlinking the RING-PCGF1 enzymatic core from target genes
|bioRxiv (Cold Spring Harbor Laboratory)|2021|0